SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kwality Pharma - Quaterly Results

23 May 2024 Evaluate
The sales for the March 2024 quarter moved up 33.68% to Rs. 919.77 millions as compared to Rs. 688.04 millions during the corresponding quarter last year.The Total Profit for the quarter ended March 2024 of Rs. 44.96 millions grew from Rs.-73.55 millionsOperating profit surged to 214.42 millions from the corresponding previous quarter of 129.79 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 919.77 688.04 33.68 3071.72 2509.95 22.38 3071.72 2509.95 22.38
Other Income 5.83 14.60 -60.07 18.30 29.41 -37.78 18.30 29.41 -37.78
PBIDT 214.42 129.79 65.21 684.63 632.29 8.28 684.63 632.29 8.28
Interest 30.57 16.68 83.27 103.87 60.20 72.54 103.87 60.20 72.54
PBDT 112.86 -52.18 -316.29 509.77 406.80 25.31 509.77 406.80 25.31
Depreciation 50.43 44.16 14.20 195.11 149.19 30.78 195.11 149.19 30.78
PBT 62.43 -96.34 -164.80 314.66 257.61 22.15 314.66 257.61 22.15
TAX 17.47 -22.79 -176.66 74.83 62.93 18.91 74.83 62.93 18.91
Deferred Tax 1.76 1.67 5.39 -4.37 1.37 -418.98 -4.37 1.37 -418.98
PAT 44.96 -73.55 -161.13 239.83 194.68 23.19 239.83 194.68 23.19
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 23.31 18.86 23.58 22.29 25.19 -11.52 22.29 25.19 -11.52

Kwality Pharma Share Price

1664.30 -82.70 (-4.73%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×